Effectiveness of neoadjuvant intralesional methotrexate in cutaneous squamous cell carcinoma: a prospective cohorts study

Prospective Cohorts

Cutaneous Squamous Cell Carcinoma Treated With Mohs Micrographic Surgery in Australia. II. Perineural Invasion

Yearbook of Dermatology and Dermatologic Surgery ◽

10.1016/s0093-3619(08)70229-6 ◽

2006 ◽

Vol 2006 ◽

pp. 284

Author(s):

J. Cook

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Perineural Invasion ◽

Mohs Micrographic Surgery ◽

Micrographic Surgery

No Evidence for Increased Risk of Cutaneous Squamous Cell Carcinoma in Patients With Rheumatoid Arthritis Receiving Etanercept for Up to 5 Years

Yearbook of Dermatology and Dermatologic Surgery ◽

10.1016/s0093-3619(08)70149-7 ◽

2006 ◽

Vol 2006 ◽

pp. 195

Author(s):

B.H. Thiers

Keyword(s):

Rheumatoid Arthritis ◽

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Increased Risk

Cutaneous Squamous Cell Carcinoma of the Head and Neck pT4b TNM Finding v8

10.32388/92nb8v ◽

2020 ◽

Author(s):

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Cutaneous Squamous Cell Carcinoma of the Head and Neck cN1 TNM Finding v8

10.32388/wha458 ◽

2020 ◽

Author(s):

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Dermal granulomatous inflammation to cornified cells. Significance near cutaneous squamous cell carcinoma

Archives of Dermatology ◽

10.1001/archderm.128.5.649 ◽

1992 ◽

Vol 128 (5) ◽

pp. 649-652 ◽

Cited By ~ 1

Author(s):

B. Leshin

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Granulomatous Inflammation ◽

A Case of Anti-TIF1-γ Antibody-positive Dermatomyositis with Cutaneous Squamous Cell Carcinoma

Nishi Nihon Hifuka ◽

10.2336/nishinihonhifu.80.331 ◽

2018 ◽

Vol 80 (4) ◽

pp. 331-335

Author(s):

Reika FUKUCHI ◽

Sayaka KUWATSUKA ◽

Yukie SATO ◽

Yutaka KUWATSUKA ◽

Atsushi UTANI

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Multidisciplinary Expert-Driven Consensus on the Evolving Treatment of Patients with Advanced Cutaneous Squamous Cell Carcinoma

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.3.supp.50 ◽

2019 ◽

Vol 3 ◽

pp. S50

Author(s):

Michael R Migden ◽

Todd E Schlesinger ◽

Chrysalyne D Schmults ◽

Scott M Dinehart ◽

Robert L Ferris ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Abstract not available.

Tumor cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma

10.26226/morressier.595a9c59d462b80296ca01a3 ◽

2017 ◽

Author(s):

Pilvi Riihilä

Keyword(s):

Squamous Cell Carcinoma ◽

Tumor Cell ◽

Cell Carcinoma ◽

Squamous Cell ◽

Complement Components

Molecular Signatures of Cutaneous Squamous Cell Carcinoma During Recessive Dystrophic Epidermolysis Bullosa

Case Medical Research ◽

10.31525/ct1-nct04285294 ◽

2020 ◽

Author(s):

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Epidermolysis Bullosa ◽

Recessive Dystrophic Epidermolysis Bullosa

Molecular Signatures ◽

Dystrophic Epidermolysis Bullosa ◽

Faculty Opinions recommendation of Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717952969.793458516 ◽

2012 ◽

Author(s):

Johann Bauer ◽

Verena Wally ◽

Eva Murauer

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Epidermolysis Bullosa ◽

Recessive Dystrophic Epidermolysis Bullosa

Dermal Matrix ◽

Dystrophic Epidermolysis Bullosa ◽